Login
Olema Pharmaceuticals, Inc. logo

Olema Pharmaceuticals, Inc.

olema.com

What Do They Do?

Develops targeted drug candidates to treat breast and other cancers in patients.

How Do They Make Money?

No revenue reported yet.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▼ −74% (Loss)
vs −$42.2M in Q3 FY2025
  • Aug 13, 2026 Olema appointed Jason O’Byrne as chief financial officer

Scope beyond breast cancer The earlier report framed the company around therapies for women’s cancers; the latest also describes work on candidates for other cancers, alongside its breast cancer programs.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support